Clinical Trial News and Research

RSS
Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee

Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee

18 Apr 2013
Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

17 Apr 2013
GlycoMimetics reports Phase 2 clinical study results of GMI-1070

GlycoMimetics reports Phase 2 clinical study results of GMI-1070

17 Apr 2013
Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

17 Apr 2013
COPD phase III study by Almirall and Forest Laboratories announces positive results

COPD phase III study by Almirall and Forest Laboratories announces positive results

16 Apr 2013
Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

16 Apr 2013
Benitec to conduct phase I/II clinical trial of TT-034 in patients with HCV in UCSD site

Benitec to conduct phase I/II clinical trial of TT-034 in patients with HCV in UCSD site

16 Apr 2013
NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

16 Apr 2013
Death of heart tissue could be prevented with new medicines, say TUSM scientists

Death of heart tissue could be prevented with new medicines, say TUSM scientists

15 Apr 2013
FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

FDA accepts Otsuka Pharmaceutical's tolvaptan NDA for priority review

15 Apr 2013
Researchers suggest web-based tools to recruit study participants for clinical pain trials

Researchers suggest web-based tools to recruit study participants for clinical pain trials

15 Apr 2013
Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

Navidea presents Phase 3 Lymphoseek study results at international symposium in Athens

15 Apr 2013
UCLA physicians perform new procedure to clear plaque-ridden carotid arteries

UCLA physicians perform new procedure to clear plaque-ridden carotid arteries

15 Apr 2013
Nalmefene can provide important clinical benefit for alcohol-dependent patients

Nalmefene can provide important clinical benefit for alcohol-dependent patients

12 Apr 2013
Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

12 Apr 2013
Sorbent Therapeutics starts patient dosing in Phase 2b clinical trial of CLP-1001

Sorbent Therapeutics starts patient dosing in Phase 2b clinical trial of CLP-1001

12 Apr 2013
Gabriel Hortobagyi recognized with AACR-MICR Jane Cooke Wright Lectureship

Gabriel Hortobagyi recognized with AACR-MICR Jane Cooke Wright Lectureship

12 Apr 2013
OncoMed highlights progress of anti-cancer biologics at AACR annual meeting

OncoMed highlights progress of anti-cancer biologics at AACR annual meeting

11 Apr 2013
DelMar Pharmaceuticals reports positive results from VAL-083 Phase I/II clinical trial in patients with GBM

DelMar Pharmaceuticals reports positive results from VAL-083 Phase I/II clinical trial in patients with GBM

11 Apr 2013
First-in-humans study introduces next generation cell therapy for heart failure patients

First-in-humans study introduces next generation cell therapy for heart failure patients

11 Apr 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback